tiprankstipranks
Advertisement
Advertisement

INMB Stock Latest News

INmune Bio Strengthens Cash Runway With R&D Rebates
Company AnnouncementsINmune Bio Strengthens Cash Runway With R&D Rebates
2d ago
8K
INMB
INmune Bio receives $4.6M in rebates from Australia, UK
PremiumThe Fly
INmune Bio receives $4.6M in rebates from Australia, UK
2d ago
INMB
INmune Bio processes first umbilical cord tissue at CGT Catapult
PremiumThe Fly
INmune Bio processes first umbilical cord tissue at CGT Catapult
13d ago
INMB
Strengthening XPro1595 Data and De-Risked Registrational Path Support Buy Rating on INmune Bio with Unchanged $8 Price Target
PremiumRatings
Strengthening XPro1595 Data and De-Risked Registrational Path Support Buy Rating on INmune Bio with Unchanged $8 Price Target
23d ago
INMB
INmune Bio Executes Warrant Inducement and Extension Agreement
PremiumCompany Announcements
INmune Bio Executes Warrant Inducement and Extension Agreement
1M ago
8K
INMB
INmune Bio advances CORDStrom platform patent application in the U.S.
PremiumThe FlyINmune Bio advances CORDStrom platform patent application in the U.S.
1M ago
INMB
INmune Bio receives MHRA approval for Ebstrocel pediatric investigation plan
Premium
The Fly
INmune Bio receives MHRA approval for Ebstrocel pediatric investigation plan
1M ago
INMB
INmune Bio Advances Ebstrocel Toward UK Conditional Approval
Premium
Company Announcements
INmune Bio Advances Ebstrocel Toward UK Conditional Approval
1M ago
8K
INMB
INmune Bio announces MHRA alignment in pre-MAA CORDStrom meeting
PremiumThe Fly
INmune Bio announces MHRA alignment in pre-MAA CORDStrom meeting
1M ago
INMB
Inmune Bio Shareholders Reaffirm Board, Auditor and Incentive Plan
PremiumCompany Announcements
Inmune Bio Shareholders Reaffirm Board, Auditor and Incentive Plan
2M ago
8K
INMB
Maintained Buy on INmune Bio as Compelling Phase 2 Alzheimer’s Data Support XPro1595; $8 Price Target Reiterated
PremiumRatings
Maintained Buy on INmune Bio as Compelling Phase 2 Alzheimer’s Data Support XPro1595; $8 Price Target Reiterated
2M ago
INMB
INmune Bio reports positive Phase 2 MRI results
PremiumCompany Announcements
INmune Bio reports positive Phase 2 MRI results
2M ago
8K
INMB
INmune Bio reports positive MRI data in Phase 2 Alzheimer’s trial
PremiumThe FlyINmune Bio reports positive MRI data in Phase 2 Alzheimer’s trial
2M ago
INMB
Inmune Bio Charts Regulatory Path Amid Cash Constraints
Premium
Company Announcements
Inmune Bio Charts Regulatory Path Amid Cash Constraints
2M ago
INMB
INmune Bio publishes MINDFuL trial results in NPJ Dementia
Premium
The Fly
INmune Bio publishes MINDFuL trial results in NPJ Dementia
3M ago
INMB
INmune Bio Receives FDA Fast Track for XPro
PremiumCompany Announcements
INmune Bio Receives FDA Fast Track for XPro
3M ago
8K
INMB
INmune Bio receives fast track designation from FDA for XPro
PremiumThe Fly
INmune Bio receives fast track designation from FDA for XPro
3M ago
INMB
Inmune Bio Advances CORDStrom Amid Funding Pressures
PremiumCompany Announcements
Inmune Bio Advances CORDStrom Amid Funding Pressures
3M ago
INMB
INmune Bio Expands Cord Tissue License for CORDStrom Platform
PremiumCompany Announcements
INmune Bio Expands Cord Tissue License for CORDStrom Platform
3M ago
8K
INMB
INmune Bio announces new preclinical data for INB03
PremiumThe FlyINmune Bio announces new preclinical data for INB03
4M ago
INMB
Inmune Bio Earnings Call Balances Progress and Risk
Premium
Company Announcements
Inmune Bio Earnings Call Balances Progress and Risk
4M ago
INMB
INMB Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
INMB Upcoming Earnings Report: What to Expect?
4M ago
INMB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >